A Post Marketing Study in Participants With Early Alzheimer’s Disease Treated With Lecanemab
Condition(s):Alzheimer’s DiseaseLast Updated:March 21, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Alzheimer’s DiseaseLast Updated:March 21, 2024Recruiting
Condition(s):Sleep Initiation and Maintenance DisordersLast Updated:October 27, 2023Recruiting
Condition(s):Lymphoma, FollicularLast Updated:December 18, 2023Recruiting
Condition(s):Hepatic ImpairmentLast Updated:March 19, 2024Recruiting
Condition(s):Solid TumorsLast Updated:February 9, 2024Recruiting
Condition(s):Breast CancerLast Updated:April 18, 2023Recruiting
Condition(s):Alzheimer’s Disease; Mild Cognitive ImpairmentLast Updated:September 29, 2023Recruiting
Condition(s):Recurrent Hepatocellular Carcinoma; Stage III Hepatocellular Carcinoma AJCC v8; Stage IIIA Hepatocellular Carcinoma AJCC v8; Stage IIIB Hepatocellular Carcinoma AJCC v8; Stage IV Hepatocellular Carcinoma AJCC v8; Stage IVA Hepatocellular Carcinoma AJCC v8; Stage IVB Hepatocellular Carcinoma AJCC v8; Unresectable Hepatocellular CarcinomaLast Updated:June 28, 2023Recruiting
Condition(s):Breast CancerLast Updated:February 20, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.